A number of therapeutic agents targeting oncogenic growth factor signaling pathways regulated by HIF-1 have been developed during the last decades and several of them have been demonstrated to exert inhibitory effects on tumor growth [200,201]. This evidence concerns the gene HIF1A and neoplasm.